Latest Capital Raising News

The ASX has suspended trading of Canadian Phosphate Limited’s CP8O securities pending compliance with specific listing rules, a move that isolates this security class without affecting the company’s other quoted shares.

Catalina Resources has validated significant historical gold mineralisation across its newly acquired Mid-West portfolio in Western Australia, bolstering its position near key regional mining infrastructure and preparing for maiden drilling campaigns.

The GPT Wholesale Shopping Centre Fund is set to deepen its retail property exposure with a $1.2 billion acquisition of interests in two major super-regional shopping centres, Sunshine Plaza and Macarthur Square. This move leverages recent capital raises and underlines GPT's strategy to scale through partnerships.

EPX Limited has locked in a $3 million senior secured revolving loan note facility with Partners for Growth, providing capital to seize new revenue opportunities and support working capital over the next three years.

Mt Malcolm Mines has successfully closed a $1.04 million rights issue, securing capital to advance a processing plant feasibility study and exploration at its Malcolm Gold Project in Western Australia.

Anax Metals has raised $6 million through a placement of 176 million shares at 3.4 cents each, expanding its capital base without shareholder approval by utilising existing ASX placement capacity.

WCM Global Growth Limited has renewed its on-market share buy-back program for another year, signalling ongoing capital management flexibility amid evolving market conditions.

Cassius Mining Limited is issuing bonus options to eligible Australian and New Zealand shareholders, offering one new option for every eight shares held. These options carry a 3-cent exercise price and expire in mid-2029, aiming to reward loyalty without raising new capital.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

Electro Optic Systems (ASX:EOS) has dramatically expanded its Share Purchase Plan from $25 million to $40 million after receiving $95 million in applications, reflecting robust support from retail investors. Approximately 5 million new shares will be issued at $8.00 each, matching recent institutional pricing.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.

TZ Limited has voluntarily suspended trading of its shares on the ASX as it prepares to announce a significant capital raising. The suspension aims to ensure compliance with disclosure rules while the transaction is finalised.